Business briefs
Codonics strikes private label dealAurora brokers Chinese exchangeZiehm changes leadership
Codonics strikes private label deal
The computed radiography and film digitizing firm iCRco will globally distribute Codonics printer and media products under its own label as part of a partnership agreement announced Sept. 16. Software introduced by iCRco in January 2006 will complement the privately labeled products from Codonics.
Aurora brokers Chinese exchange
Researchers from China will spend up to three weeks in leading breast centers in the U.S. to learn about breast imaging modalities under a program established by the China Medical Women's Association (CMWA) and the Aurora Breast MRI Society. CMWA has 19 branches with 150 institutional members and more than 20,000 individual women physician members. The Aurora Breast MRI Society is sponsored by Aurora Imaging Technology. Dr. Zi-yang Li, executive vice president of CMWA, affirmed that new technology, Aurora Dedicated Breast MRI System, is needed in the fight against breast cancer in China.
Ziehm changes leadership
Dr. Jörg Ströbel has stepped down as managing partner of Ziehm Imaging-Aton. In his seven years at the corporate helm, Ströbel transformed Ziehm Imaging into a major innovator of mobile C-arm technology, according to the company. Klaus Hörndler and Stefan Gutsch have taken over as managing directors.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
